Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease


YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L. , ...More

DIGESTIVE AND LIVER DISEASE, vol.45, no.1, pp.58-62, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 1
  • Publication Date: 2013
  • Doi Number: 10.1016/j.dld.2012.08.017
  • Journal Name: DIGESTIVE AND LIVER DISEASE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.58-62
  • Keywords: Biomarker, Inflammation, Nonalcoholic fatty liver disease, Osteopontin, Portal inflammation, METABOLIC SYNDROME, HEPATOCELLULAR-CARCINOMA, STEATOHEPATITIS, ASSOCIATION, STEATOSIS, OBESITY, MARKER, EXPRESSION, FIBROSIS, HEDGEHOG
  • Recep Tayyip Erdoğan University Affiliated: No

Abstract

Background: Osteopontin is a secreted phosphorylated glycoprotein that is expressed by a variety of cell types and that mediates numerous and diverse biological functions.